Molecular Factors Influencing the Affinity of Flavonoid Compounds on P-Glycoprotein Efflux Transporter

被引:0
|
作者
Vazquez, Rodolfo N. [1 ,2 ]
Camargo, Alejandra B. [3 ,4 ,5 ]
Marchevsky, Eduardo J. [6 ,7 ]
Luco, Juan M. [1 ,2 ]
机构
[1] Univ Nacl San Luis, Fac Quim Bioquim & Farm, Dept Quim, RA-5700 Chacabuco, San Luis, Argentina
[2] Univ Nacl San Luis, Fac Quim Bioquim & Farm, Dept Quim, RA-5700 Pedernera, San Luis, Argentina
[3] Consejo Nacl Invest Cient & Tecn, IBAM, Mendoza, Argentina
[4] Univ Nacl Cuyo, Lab Cromatog Agroalimentos, Fac Ciencias Agr, RA-5505 Mendoza, Argentina
[5] Univ Nacl Cuyo, Fac Ciencias Exactas & Nat, RA-5505 Mendoza, Argentina
[6] Univ Nacl San Luis, Fac Quim Bioquim & Farm, Inst Quim San Luis INQUISAL, CONICET, RA-5700 Chacabuco, San Luis, Argentina
[7] Univ Nacl San Luis, Fac Quim Bioquim & Farm, Inst Quim San Luis INQUISAL, CONICET, RA-5700 Pedernera, San Luis, Argentina
关键词
Flavonoids; multivariate quantitative structure-activity relationships (QSARs); nonempirical descriptors; P-glycoprotein (Pgp); CELL MULTIDRUG-RESISTANCE; NUCLEOTIDE-BINDING DOMAIN; BLOOD-BRAIN-BARRIER; ABC TRANSPORTERS; DRUG ABSORPTION; INHIBITORS; CANCER; MECHANISMS; MODULATORS; CHALCONES;
D O I
10.2174/157340991003150302231140
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The most common mechanism of the so-called multidrug resistance (MDR), is mainly associated with an over expression of P-glycoprotein (Pgp). It is an ATP-dependent transport protein that limits the intracellular accumulation of a variety of structurally unrelated compounds within various organs and normal tissues such as kidney, small intestine and the blood brain barrier. Thus, the expression of Pgp has a major impact on the pharmacokinetic profile of many therapeutic agents and therefore, overcoming Pgp-mediated efflux constitutes an attractive means of potentially enhancing their therapeutic efficacy. The flavonoids comprise a large group of polyphenolic compounds that occur in plants and vegetables, and they have been shown to display a wide variety of biological activities. For example, anti-inflammatory, antioxidant, antiallergic, hepatoprotective, antithrombotic, antiviral, and anticarcinogenic activities. The interactions between flavonoids and Pgp have also been extensively studied and some quantitative structure-activity relationships (QSAR) have been reported. In the present work, we have employed 2D-QSAR analysis to evaluate the interactions between Pgp and several flavonoid compounds with the aim of identifying the molecular factors responsible for the Pgp-binding affinity evidenced by these compounds. Thus, the reported data for dissociation constants (KD) between Pgp and 62 flavonoid compounds were modeled by means of multiple regression analysis (MLR), and structures of the compounds under study were characterized by means of calculated physicochemical properties and several topological and constitutional descriptors, as well as geometrical and quantum chemical indexes. The obtained results suggest that the hydrophobic and especially geometric factors are of prime importance for binding, whereas in the case of flavonoid derivatives with flavone (flavonols), flavanone and isoflavone nuclei, the electronic factors are also involved in electron donor/acceptor interactions. In addition, in the case of chalcones, the results suggest that the affinity toward P-gp of such compounds is mainly governed by intermolecular dispersive interactions at the binding site.
引用
收藏
页码:250 / 258
页数:9
相关论文
共 50 条
  • [1] Individual and dual combined effects of flavonoid compounds on the inhibition of the P-glycoprotein drug efflux transporter
    Ferreira, A. F.
    Rodrigues, M.
    Santos, A.
    Fortuna, A.
    Falcao, A.
    Alves, G.
    JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 114 - 114
  • [2] The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone
    Karssen, AM
    Meijer, OC
    van der Sandt, ICJ
    De Boer, AG
    De Lange, ECM
    De Kloet, ER
    JOURNAL OF ENDOCRINOLOGY, 2002, 175 (01) : 251 - 260
  • [3] Molecular analysis of the multidrug transporter, P-glycoprotein
    Germann, UA
    Chambers, TC
    CYTOTECHNOLOGY, 1998, 27 (1-3) : 31 - 60
  • [4] Molecular analysis of the multidrug transporter, P-glycoprotein
    Ursula A. Germann
    Timothy C. Chambers
    Cytotechnology, 1998, 27 : 31 - 60
  • [5] Pharmacokinetics of Quinacrine Efflux from Mouse Brain via the P-glycoprotein Efflux Transporter
    Ahn, Misol
    Ghaemmaghami, Sina
    Huang, Yong
    Phuan, Puay-Wah
    May, Barnaby C. H.
    Giles, Kurt
    DeArmond, Stephen J.
    Prusiner, Stanley B.
    PLOS ONE, 2012, 7 (07):
  • [6] Interactions of Pesticides with Drug Efflux Transporter P-glycoprotein in the European Honeybee
    Pouv, Amara
    Nicklisch, Sascha
    FASEB JOURNAL, 2020, 34
  • [7] Inhibition of anticancer drug efflux transporter P-glycoprotein by rosemary phytochemicals
    Nabekura, Tomohiro
    Yamaki, Takeshi
    Hiroi, Takashi
    Ueno, Kazuyuki
    Kitagawa, Shuji
    PHARMACOLOGICAL RESEARCH, 2010, 61 (03) : 259 - 263
  • [8] Dietary flavonoids induced the activity of P-glycoprotein, an efflux drug transporter
    Yu, Chung-Ping
    Hariharan, Parameswaran
    Tsai, Shang-Yuan
    Hou, Yu-Chi
    Chao, Pei-Dawn Lee
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [9] Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein
    Ledwitch, Kaitlyn V.
    Gibbs, Morgan E.
    Barnes, Robert W.
    Roberts, Arthur G.
    BIOCHEMICAL PHARMACOLOGY, 2016, 118 : 96 - 108
  • [10] Docking Applied to the Prediction of the Affinity of Compounds to P-Glycoprotein
    Palestro, Pablo H.
    Gavernet, Luciana
    Estiu, Guillermina L.
    Bruno Blanch, Luis E.
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014